ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+28.27%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$138M
AUM Growth
-$10.1M
(-6.8%)
Cap. Flow
+$14.2M
Cap. Flow
% of AUM
10.33%
Top 10 Holdings %
Top 10 Hldgs %
57.7%
Holding
51
New
15
Increased
8
Reduced
16
Closed
8
Top Buys
| 1 |
Taysha Gene Therapies
TSHA
|
$12.1M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$7.65M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$2.8M |
| 4 |
HilleVax
HLVX
|
$2.79M |
| 5 |
Replimune Group
REPL
|
$2.57M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$5.17M |
| 2 |
argenx
ARGX
|
$4.9M |
| 3 |
Clene
CLNN
|
$3.73M |
| 4 |
GH Research
GHRS
|
$2.9M |
| 5 |
Roivant Sciences
ROIV
|
$2.22M |
Sector Composition
| 1 | Healthcare | 99.88% |
| 2 | Consumer Staples | 0% |